LON:MDCMediclinic International Share Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Mediclinic International PLC Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add GBX 268 +3.20 (+1.21 %) (As of 05/26/2020 04:00 PM ET) Add Compare Share Today's Range 262.60Now: GBX 268▼ 270.6050-Day Range 238.20MA: GBX 259.14▼ 289.4052-Week Range 232.40Now: GBX 268▼ 419.40Volume590,986 shsAverage Volume1.61 million shsMarket Capitalization£1.98 billionP/E Ratio15.67Dividend Yield3.12%BetaN/A ProfileAnalyst RatingsAdvanced ChartCompetitorsDividendInsider TradesHeadlinesOptions Chain Mediclinic International plc, together with its subsidiaries, operates private hospitals. The company offers acute care, specialist-orientated, and multidisciplinary healthcare services under the Mediclinic and Hirslanden brand names. It operates 17 private acute care hospitals and 4 clinics with approximately 1,805 inpatient beds in Switzerland; 49 acute care private hospitals and 2 day clinics in South Africa, and 3 hospitals in Namibia with approximately 8,131 inpatient beds; and 6 acute care private hospitals and 22 clinics with approximately 748 inpatient beds in the United Arab Emirates. The company also provides treasury, hospital equipment, debt collection and related, emergency medical, management, food and catering, procurement, and healthcare management services; manages healthcare staff; and owns and manages properties. In addition, it engages in intellectual property holding and medical store/procurement businesses. Mediclinic International plc was founded in 1983 and is based in Stellenbosch, South Africa.Read More Beat the Market (BTM) Rank™ 3.1 Analyst's Opinion Consensus RatingMediclinic International has received a consensus rating of Hold. The company's average rating score is 2.20, and is based on 1 buy rating, 4 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of GBX 385.50, Mediclinic International has a potential upside of 43.8% from its current price of GBX 268.Amount of Analyst CoverageMediclinic International has only been the subject of 1 research reports in the past 90 days. Previous Next 2.0 Community Rank Outperform VotesMediclinic International has received 213 “outperform” votes. (Add your “outperform” vote.)Underperform VotesMediclinic International has received 318 “underperform” votes. (Add your “underperform” vote.)Community SentimentMediclinic International has received 59.89% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Mediclinic International and other stocks. Vote “Outperform” if you believe MDC will outperform the S&P 500 over the long term. Vote “Underperform” if you believe MDC will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 2.5 Dividend Strength Dividend LeadershipMediclinic International is a leading dividend payer. It pays a dividend yield of 3.12%, putting its dividend yield in the top 25% of dividend-paying stocks.Dividend GrowthMediclinic International does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Mediclinic International is 0.47 %. This payout ratio is at a healthy, sustainable level, below 75%. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Mediclinic International insiders have not sold or bought any company stock. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for Mediclinic International are expected to decrease by -100.00% in the coming year, from GBX 2,909 to GBX 0 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Mediclinic International is 15.67, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 13.96.Price to Earnings Ratio vs. SectorThe P/E ratio of Mediclinic International is 15.67, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 26.03.Price to Book Value per Share RatioMediclinic International has a P/B Ratio of 0.59. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next Analyst Opinion: 3.1Community Rank: 2.0Dividend Strength: 2.5Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.77 out of 5 stars Industry, Sector and Symbol Stock Exchange LON Industry Medical Care Sub-IndustryN/A SectorMedical Current SymbolLON:MDC Previous SymbolLON:ANH CUSIPN/A CIKN/A Webwww.mediclinic.com Phone+44-20-79549600Debt Debt-to-Equity Ratio78.63 Current Ratio1.83 Quick Ratio1.65Price-To-Earnings Trailing P/E Ratio15.67 Forward P/E Ratio0.09 P/E GrowthN/A Sales & Book Value Annual Sales£3.06 billion Price / Sales0.65 Cash FlowGBX 32.25 per share Price / Cash Flow8.31 Book ValueGBX 451.80 per share Price / Book0.59Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees33,629 Outstanding Shares737,211,008Market Cap£1.98 billion Next Earnings Date6/2/2020 (Estimated) OptionableOptionable LSE:MDC Rates by TradingView Receive MDC News and Ratings via Email Sign-up to receive the latest news and ratings for MDC and its competitors with MarketBeat's FREE daily newsletter. Mediclinic International (LON:MDC) Frequently Asked Questions How has Mediclinic International's stock been impacted by COVID-19 (Coronavirus)? Mediclinic International's stock was trading at GBX 335.70 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, MDC stock has decreased by 20.2% and is now trading at GBX 268. View which stocks have been most impacted by Coronavirus. Do Wall Street analysts recommend investors buy shares of Mediclinic International? 5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Mediclinic International in the last year. There are currently 4 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Mediclinic International. When is Mediclinic International's next earnings date? Mediclinic International is scheduled to release its next quarterly earnings announcement on Tuesday, June 2nd 2020. View our earnings forecast for Mediclinic International. How often does Mediclinic International pay dividends? What is the dividend yield for Mediclinic International? Mediclinic International announced a dividend on Thursday, November 14th. Shareholders of record on Thursday, December 5th will be given a dividend of GBX 3.20 per share on Tuesday, December 17th. This represents a dividend yield of 0.85%. The ex-dividend date is Thursday, December 5th. The official announcement can be accessed at this link. View Mediclinic International's dividend history. What price target have analysts set for MDC? 5 equities research analysts have issued twelve-month target prices for Mediclinic International's stock. Their forecasts range from GBX 260 to GBX 482. On average, they expect Mediclinic International's share price to reach GBX 385.50 in the next year. This suggests a possible upside of 43.8% from the stock's current price. View analysts' price targets for Mediclinic International. Has Mediclinic International been receiving favorable news coverage? Media coverage about MDC stock has trended extremely negative on Tuesday, according to InfoTrie Sentiment Analysis. The research firm identifies negative and positive media coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Mediclinic International earned a coverage optimism score of -5.0 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the company's share price in the immediate future. View the latest news aboutMediclinic International. Who are some of Mediclinic International's key competitors? Some companies that are related to Mediclinic International include Healius (HLS), Rhoen Klinikum (RHK), CareTech (CTH), Spire Healthcare Group (SPI), Virtus Health (VRT), Pacific Smiles Group (PSQ), Georgia Healthcare Group (GHG), CENTRIC HEALTH (CHH), Sanara MedTech (SMTI), Totally (TLY), Assure (IOM), Konekt (KKT), Brain Resource (BRC), NMC Health (NMC) and Nobilis Health (HLTH). View all competitors. What other stocks do shareholders of Mediclinic International own? Based on aggregate information from My MarketBeat watchlists, some companies that other Mediclinic International investors own include Intu Properties (INTU), Capital & Counties Properties PLC (CAPC), RDI Reit (RDI), British American Tobacco Plc Ads (BATS), Central Asia Metals (CAML), DRDGOLD (DRD), UK Oil & Gas (UKOG), Spire Healthcare Group (SPI), Premier Oil (PMO) and Ferrexpo (FXPO). Who are Mediclinic International's key executives? Mediclinic International's management team includes the following people: Mr. Petrus Jurgens Myburgh, Group CFO & Exec. Director (Age 44)Mr. Ronnie van der Merwe, CEO & Exec. DirectorDr. Dirk C. Le Roux, Chief Information Officer (Age 59)Mr. James Arnold, Head of Investor RelationsMr. Magnus U. Oetiker, Chief HR Officer (Age 47) What is Mediclinic International's stock symbol? Mediclinic International trades on the London Stock Exchange (LON) under the ticker symbol "MDC." How do I buy shares of Mediclinic International? Shares of MDC and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What is Mediclinic International's stock price today? One share of MDC stock can currently be purchased for approximately GBX 268. How big of a company is Mediclinic International? Mediclinic International has a market capitalization of £1.98 billion and generates £3.06 billion in revenue each year. Mediclinic International employs 33,629 workers across the globe. What is Mediclinic International's official website? The official website for Mediclinic International is www.mediclinic.com. How can I contact Mediclinic International? Mediclinic International's mailing address is 6th Floor 65 Gresham Street, LONDON, EC2V 7NQ, United Kingdom. The company can be reached via phone at +44-20-79549600. This page was last updated on 5/26/2020 by MarketBeat.com Staff
